Evidence map›Paper›PMID 37089924›Full record

ArticleFrontiers in pharmacology2023

Naoxin'an capsules protect brain function and structure in patients with vascular cognitive impairment.

Hui Lu, Mingxi Dang, Kewei Chen, Huajie Shang, Bolong Wang, Shaokun Zhao, Xin Li, Zhanjun Zhang, Junying Zhang, Yaojing Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hui LuState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Mingxi DangState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Kewei ChenBanner Alzheimer's Institute, Phoenix, AZ, United States.
Huajie ShangState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Bolong WangState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Shaokun ZhaoState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Xin LiState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Zhanjun ZhangState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Junying ZhangInstitute of Basic Research in Clinical Medicine, China Academy of Traditional Chinese Medicine, Beijing, China.
Yaojing ChenState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Beijing Normal University · CNBanner Alzheimer’s InstituteSichuan Academy of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

brain functionleft middle frontal gyrusNaoxin’an capsulepostcentral gyrustraditional Chinese medicinevascular cognitive impairment

Identifiers

PMID37089924
PMCPMC10113453
OpenAlexW4362626087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.